Brighton Jones’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Brighton Jones's IBB Position: Q3 2026 in Review
Brighton Jones reduced its iShares Biotechnology ETF (IBB) stake by 2% in Q3 2026, selling an estimated $10K and leaving 2,441 shares worth $514K. The position accounts for 0.01% of the portfolio, ranked #792.
Brighton Jones first reported a position in IBB in Q3 2013 and has held it in 17 quarters since. The position peaked at $772K in Q3 2017. 924 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Brighton Jones held 2,441 shares of iShares Biotechnology ETF worth $514K as of Q3 2026.
- Brighton Jones sold 50 iShares Biotechnology ETF shares in Q3 2026, an estimated $10K.
- iShares Biotechnology ETF made up 0.01% of Brighton Jones's portfolio in Q3 2026, its #792 holding.
- Brighton Jones first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 17 quarters since.
- Brighton Jones's iShares Biotechnology ETF position peaked at $772K in Q3 2017.
- 924 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.